for BIKTARVY. BIKTARVY ...
Gilead Sciences 1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BIKTARVY safely and effectively.
Download for BIKTARVY. BIKTARVY ...
Information
Domain:
Source:
Link to this page:
Documents from same domain
-800 GILEAD5 or FDA at 1800 FDA 1088 or …
www.gilead.comHIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZYDELIG safely and effectively. See full prescribing information
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.gilead.com3 full prescribing information warning: posttreatment acute exacerbation of hepatitis b and risk of drug resistance with use of truvada for hiv-1 pre-
AmBisome (amphotericin B) liposome for injection
www.gilead.com5 Pediatric and Elderly Patients The pharmacokinetics of amphotericin B after administration of AmBisome in pediatric and elderly patients has not been studied; however, AmBisome has
(incidence greater than or equal to 10%, Grades 2
www.gilead.com1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VIREAD safely and effectively. DSee full prescribing information …
AMENDED AND RESTATED LICENSE AGREEMENT …
www.gilead.comFinal Version 1 AMENDED AND RESTATED LICENSE AGREEMENT (TEMPLATE) This AMENDED AND RESTATED LICENSE AGREEMENT (the “Agreement”) is made as of July __, 2011 (the “Effective Date”) by and between Gilead Sciences, Inc. a
HIGHLIGHTS OF PRESCRIBING INFORMATION 4, 5, …
www.gilead.com1 HIGHLIGHTS OF PRESCRIBING INFORMATION 4, 5, or 6 These highlights do not include all the information needed to use HARVONI ® safely and effectively. See full prescribing information
LETAIRIS for LETAIRIS ...
www.gilead.com2 FULL PRESCRIBING INFORMATION WARNING: EMBRYO-FETAL TOXICITY Do not administer Letairis to a pregnant female because it may cause fetal harm.
MEDICATION GUIDE ZYDELIG (zye-DEL-ig) …
www.gilead.comMEDICATION GUIDE ZYDELIG® (zye-DEL-ig) (idelalisib) tablets What is the most important information I should know about Zydelig? Zydelig can cause serious side effects that can lead to death, including:
HIGHLIGHTS OF PRESCRIBING INFORMATION should only be …
www.gilead.com1 INDICATIONS AND USAGE . 1.1 HIV-1 Infection . VIREAD ® is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric …
Hepatitis B and C Treatment Expansion - gilead.com
www.gilead.comProviding treatment for chronic viral hepatitis B (HBV) and hepatitis C (HCV) infection is a key focus of Gilead Sciences. We make it a priority to expand access to treatment for appropriate patients in need in developing countries.
Related documents
Pre -Exposure Prophylaxis (PrEP): A primer for …
sfcityclinic.orgPre -Exposure Prophylaxis (PrEP): A primer for primary care providers Rev 5.26.14 Daily emtricitabine/tenofovir (Truvada®) is safe and effective for reducing the risk of HIV acquisition in sexually active
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.gilead.com3 full prescribing information warning: posttreatment acute exacerbation of hepatitis b and risk of drug resistance with use of truvada for hiv-1 pre-
Tenofovir alafenamide and besifovir - kasl.org
www.kasl.org이현웅 | Tenofovir alafenamide and besifovir www.kasl.org 47 2. 치료 효과, 내성 및 안전성 28명의 아시아인 중 HBeAg 양성, 고바이러스 …
NEW ZEALAND DATA SHEET (TENOFOVIR …
www.medsafe.govt.nzTRUVADA must not be administered to children or adolescents under the age of 18 years. TRUVADA is a fixed-dose combination of tenofovir disoproxil fumarate and emtricitabine.
Information to be included with an application for ...
www.who.intWHO MODEL LIST OF ESSENTIAL MEDICINES APPLICATION Information to be included with an application for inclusion, change or deletion of a medicine in the WHO Model List of Essential Medicines: